The BURAN Study of Buparlisib (AN2025) In Combination With Paclitaxel Compared to Paclitaxel Alone, in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
For more information about the trial above please contact the study team:
Principal Investigator, John Kaczmar, at firstname.lastname@example.org, or please call +1 843-792-6691.
Study Coordinator, Nikki Hill, at email@example.com.
Trial opened at the following institutions: Medical University of South Carolina